Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1797 1798 1799
This examiner grants 68% of resolved cases
Lenora A. Abel is assigned to Art Unit 1651 within Tech Center 1700 and has completed 205 resolved cases. The examiner maintains an allowance rate of 68.3 percent, which is paired with a median days to allowance of 1173. These figures provide a statistical foundation for predicting both the outcome and the duration of the patent prosecution process in this art unit. The 1173-day median pendency is a key metric for applicants to use when forecasting their intellectual property timelines.
A notable statistic is the interview lift of 34.5 percent. This suggests that conducting an interview is an effective tactic for increasing the chances of allowance beyond the 68.3 percent baseline. With 205 resolved cases, the data supports the use of interviews to navigate the 1173-day timeline. Practitioners should view the 34.5 percent lift as a primary tool for securing a grant during prosecution. This lift indicates that verbal advocacy can significantly alter the trajectory of an application under this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18507648 | SYSTEMS AND METHODS FOR HEAT EXCHANGE | Non-Final OA | 10x Genomics, Inc. |
| 18508934 | COMPACT, MICROCOMPOSITE GAS FILTER | Non-Final OA | QUALCOMM Incorporated |
| 18482871 | Direct Air Capture and Bioelectrochemical Conversion of CO2 | Non-Final OA | The Regents of the University of California |
| 18637872 | Modular Solid Nano-Bioreactor | Non-Final OA | Government of the United States as represented by the Secretary of the Air Force |
| 18569525 | Biological Indicator with Adjusted Resistance Characteristics | Non-Final OA | 3M INNOVATIVE PROPERTIES COMPANY |
| 18813753 | METHODS AND SYSTEMS FOR CYCLICALLY INFLATING AND DEFLATING A LUNG EX-VIVO | Non-Final OA | Paragonix Technologies, Inc. |
| 18119653 | ORGAN TRANSPORT TRACKING | Final Rejection | Paragonix Technologies, Inc. |
| 18460266 | FAULTY UNIT DETECTION SYSTEM AND METHODS | Final Rejection | Cepheid |
| 16490419 | DEVICES, METHODS, AND COMPOSITIONS USEFUL IN CRYO-PRESERVATION, -STORAGE, -TRANSPORT, AND APPLICATION OF THERAPEUTIC MAMMALIAN CELLS | Non-Final OA | DiscGenics, Inc. |
| 18270931 | LARGE CELLULAR MICROCOMPARTMENTS COMPRISING A PLURALITY OF CYSTS | Final Rejection | TREEFROG THERAPEUTICS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy